SUDOSCAN in Oncology : Chemotherapy InduCed Polyneuropathy Two studies evaluating SUDOSCANSevere drug-induced neurotoxic adverse effects constitute the second most common cause of dose limitation after haematological adverse effects. Chemotherapy Induced…
The french newspaper "Le Monde" presenting Impeto Medical and the SUDOSCAN.
Sudoscan in the "2016 Guidelines on the management of diabetic patients. A position of Diabetes Poland." (English excerpt of the publication) Araszkiewicz A et al. 2016 Guidelines on the…
Article d'Armelle Bohineust - Paru dans le Figaro Economie le 21 novembre 2016 Impeto lance le dépistage du diabète en pharmacie Un appareil étudiant la transpiration des pieds et des…
Meet us on the next 2019 medical congress.
Identification and follow-up
of the at risk diabetic foot
Chemotherapy Indued Polyneuropathy
Two studies evaluating SUDOSCAN